This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Swearingen B et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83: 3419–3426
Melmed S et al. (2002) Guidelines for acromegaly management. J Clin Endocrinol Metab 87: 4054–4058
Vance ML and Laws ER Jr (2005) Role of medical therapy in the management of acromegaly. Neurosurgery 56: 877–885
Acknowledgements
The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Baumann, G. How effective is octreotide-LAR as a primary treatment for growth-hormone-secreting tumors?. Nat Rev Endocrinol 2, 482–483 (2006). https://doi.org/10.1038/ncpendmet0267
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0267